JP2012515195A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012515195A5 JP2012515195A5 JP2011545788A JP2011545788A JP2012515195A5 JP 2012515195 A5 JP2012515195 A5 JP 2012515195A5 JP 2011545788 A JP2011545788 A JP 2011545788A JP 2011545788 A JP2011545788 A JP 2011545788A JP 2012515195 A5 JP2012515195 A5 JP 2012515195A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- composition
- deoxyactagardine
- composition according
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 15
- 208000015181 infectious disease Diseases 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 9
- 230000000813 microbial effect Effects 0.000 claims description 9
- 241000193163 Clostridioides difficile Species 0.000 claims description 6
- 210000001072 colon Anatomy 0.000 claims description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 3
- 150000004677 hydrates Chemical class 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000012453 solvate Substances 0.000 claims description 3
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000007911 parenteral administration Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- -1 pyrrolidino-phosphonium hexafluorophosphate Chemical compound 0.000 claims description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 6
- 108010053762 deoxyactagardine B Proteins 0.000 claims 4
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 claims 3
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 2
- 241000983982 Actinoplanes liguriensis Species 0.000 claims 1
- 206010071061 Small intestinal bacterial overgrowth Diseases 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 claims 1
- 230000007142 small intestinal bacterial overgrowth Effects 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14449009P | 2009-01-14 | 2009-01-14 | |
| US61/144,490 | 2009-01-14 | ||
| PCT/GB2010/000042 WO2010082018A1 (en) | 2009-01-14 | 2010-01-12 | Deoxyactagardine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012515195A JP2012515195A (ja) | 2012-07-05 |
| JP2012515195A5 true JP2012515195A5 (https=) | 2013-03-07 |
| JP5719312B2 JP5719312B2 (ja) | 2015-05-13 |
Family
ID=42110329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011545788A Expired - Fee Related JP5719312B2 (ja) | 2009-01-14 | 2010-01-12 | デオキシアクタガルジン誘導体 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US8283371B2 (https=) |
| EP (1) | EP2387580B1 (https=) |
| JP (1) | JP5719312B2 (https=) |
| KR (1) | KR20110119699A (https=) |
| CN (1) | CN102348718B (https=) |
| AU (1) | AU2010205472B2 (https=) |
| CA (1) | CA2749278A1 (https=) |
| DK (1) | DK2387580T3 (https=) |
| EA (1) | EA021683B1 (https=) |
| ES (1) | ES2520165T3 (https=) |
| HR (1) | HRP20141084T1 (https=) |
| IL (1) | IL213927A0 (https=) |
| MX (1) | MX2011007313A (https=) |
| NZ (1) | NZ594011A (https=) |
| PL (1) | PL2387580T3 (https=) |
| PT (1) | PT2387580E (https=) |
| RS (1) | RS53586B1 (https=) |
| SG (1) | SG172944A1 (https=) |
| SI (1) | SI2387580T1 (https=) |
| TW (1) | TWI453029B (https=) |
| WO (1) | WO2010082018A1 (https=) |
| ZA (1) | ZA201104991B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0600928D0 (en) | 2006-01-17 | 2006-02-22 | Novacta Biosystems Ltd | Improvements relating to lantibiotics |
| GB0714029D0 (en) * | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | Lantibiotic-based compounds having antimicrobial activity |
| GB0714030D0 (en) * | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | The use of type-B lantibiotic-based compounds having antimicrobial activity |
| CA2749278A1 (en) | 2009-01-14 | 2010-07-22 | Novacta Biosystems Limited | Deoxyactagardine derivatives |
| CN102388060B (zh) | 2009-02-04 | 2014-09-10 | 诺瓦克塔生物系统有限公司 | 阿肽加定衍生物 |
| WO2011061748A1 (en) * | 2009-11-19 | 2011-05-26 | Strides Arcolab Limited | Rifaximin premix |
| GB201001688D0 (en) | 2010-02-02 | 2010-03-17 | Novacta Biosystems Ltd | Compounds |
| GB201013507D0 (en) * | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Compounds |
| GB201013508D0 (en) * | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Compounds |
| GB201013513D0 (en) * | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Formulations |
| GB201013509D0 (en) * | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Compounds |
| GB201213434D0 (en) | 2012-07-27 | 2012-09-12 | Novacta Biosystems Ltd | The use of type-B lantibiotic-based compounds having antimicrobial activity |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) * | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| GB8507528D0 (en) * | 1985-03-22 | 1985-05-01 | Lepetit Spa | Basis monocarboxyamide derivatives |
| US5304540A (en) | 1988-06-22 | 1994-04-19 | Applied Microbiology, Inc. | Pharmaceutical bacteriocin compositions and methods for using the same |
| IN167138B (https=) * | 1988-08-17 | 1990-09-01 | Hoechst India | |
| GB8926639D0 (en) | 1989-11-24 | 1990-01-17 | Agricultural & Food Res | Delayed release formulations |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| IT1260505B (it) | 1992-06-01 | 1996-04-09 | Poli Ind Chimica Spa | Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon |
| IL107887A (en) * | 1992-12-08 | 2003-07-06 | Ambi Inc | Stabilized lanthionine containing bacteriocin compositions |
| US5512269A (en) | 1993-06-09 | 1996-04-30 | Burroughs Wellcome, Co. | Method of treating retained pulmonary secretions |
| EP0700998B1 (en) * | 1994-09-12 | 2003-11-26 | Aventis Pharma Deutschland GmbH | Recombinant mersacidin and a method for production |
| NZ311535A (en) | 1995-06-23 | 2001-05-25 | Ambi Inc | A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| US5958873A (en) | 1997-06-09 | 1999-09-28 | University Of Cincinnati | Oral formulation for treatment of bacteria-induced diseases of the colon |
| US5985823A (en) * | 1997-06-09 | 1999-11-16 | Ambi Inc. | Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
| DE19745583A1 (de) | 1997-10-15 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben |
| US6569830B1 (en) * | 1999-03-05 | 2003-05-27 | Ambi, Inc. | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains |
| KR100786927B1 (ko) | 2000-06-28 | 2007-12-17 | 스미스클라인비이참피이엘시이 | 습식 분쇄방법 |
| GB0110432D0 (en) | 2001-04-27 | 2001-06-20 | Plant Bioscience Ltd | Lantibiotic production |
| WO2002103010A1 (en) | 2001-06-14 | 2002-12-27 | Plant Bioscience Limited | Methods and materials for targeted gene disruption in actinomycete bacteria |
| US6861236B2 (en) | 2002-05-24 | 2005-03-01 | Applied Nanosystems B.V. | Export and modification of (poly)peptides in the lantibiotic way |
| AU2003275129A1 (en) | 2002-10-10 | 2004-05-04 | Molichem Medicines, Inc. | Nucleic acids encoding duramycin |
| US7351687B2 (en) | 2003-07-18 | 2008-04-01 | Vicuron Pharmaceuticals, Inc. | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| ES2281808T3 (es) | 2003-07-18 | 2007-10-01 | Vicuron Pharmaceuticals, Inc. | Antibiotico 107891, sus factores a1 y a2, composiciones y sales farmaceuticamente aceptables y uso del mismo. |
| GB0406870D0 (en) | 2004-03-26 | 2004-04-28 | Novacta Biosystems Ltd | Improvements relating to the production of lantibiotics |
| WO2007036706A1 (en) | 2005-09-27 | 2007-04-05 | Novacta Biosystems Limited | Variants of the lantibiotic mersacidin and their use |
| GB0600928D0 (en) * | 2006-01-17 | 2006-02-22 | Novacta Biosystems Ltd | Improvements relating to lantibiotics |
| CN101595133B (zh) | 2006-10-27 | 2012-11-14 | 比利时胶囊公司 | 羟丙基甲基纤维素硬胶囊及制备方法 |
| CA2690267A1 (en) | 2007-06-12 | 2008-12-18 | The University Of British Columbia | Small cationic antimicrobial peptides |
| GB0714030D0 (en) | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | The use of type-B lantibiotic-based compounds having antimicrobial activity |
| GB0714029D0 (en) | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | Lantibiotic-based compounds having antimicrobial activity |
| KR20110086582A (ko) | 2008-11-24 | 2011-07-28 | 센티넬라 파마세티컬즈, 인크. | 항균활성이 강화된 란티바이오틱 카르복시아미드 유도체 |
| CA2749278A1 (en) | 2009-01-14 | 2010-07-22 | Novacta Biosystems Limited | Deoxyactagardine derivatives |
| GB0900599D0 (en) | 2009-01-14 | 2009-02-18 | Novacta Biosystems Ltd | Treatment |
| CN102388060B (zh) | 2009-02-04 | 2014-09-10 | 诺瓦克塔生物系统有限公司 | 阿肽加定衍生物 |
-
2010
- 2010-01-12 CA CA2749278A patent/CA2749278A1/en not_active Abandoned
- 2010-01-12 KR KR1020117018725A patent/KR20110119699A/ko not_active Withdrawn
- 2010-01-12 EA EA201190071A patent/EA021683B1/ru not_active IP Right Cessation
- 2010-01-12 NZ NZ594011A patent/NZ594011A/en not_active IP Right Cessation
- 2010-01-12 HR HRP20141084AT patent/HRP20141084T1/hr unknown
- 2010-01-12 CN CN201080012769.5A patent/CN102348718B/zh not_active Expired - Fee Related
- 2010-01-12 PL PL10700336T patent/PL2387580T3/pl unknown
- 2010-01-12 SG SG2011050416A patent/SG172944A1/en unknown
- 2010-01-12 AU AU2010205472A patent/AU2010205472B2/en not_active Ceased
- 2010-01-12 SI SI201030767T patent/SI2387580T1/sl unknown
- 2010-01-12 TW TW099100713A patent/TWI453029B/zh not_active IP Right Cessation
- 2010-01-12 US US12/686,135 patent/US8283371B2/en not_active Expired - Fee Related
- 2010-01-12 JP JP2011545788A patent/JP5719312B2/ja not_active Expired - Fee Related
- 2010-01-12 WO PCT/GB2010/000042 patent/WO2010082018A1/en not_active Ceased
- 2010-01-12 MX MX2011007313A patent/MX2011007313A/es active IP Right Grant
- 2010-01-12 ES ES10700336.0T patent/ES2520165T3/es active Active
- 2010-01-12 DK DK10700336.0T patent/DK2387580T3/da active
- 2010-01-12 PT PT107003360T patent/PT2387580E/pt unknown
- 2010-01-12 EP EP10700336.0A patent/EP2387580B1/en active Active
- 2010-01-12 RS RSP20140585 patent/RS53586B1/sr unknown
-
2011
- 2011-07-05 IL IL213927A patent/IL213927A0/en unknown
- 2011-07-07 ZA ZA2011/04991A patent/ZA201104991B/en unknown
-
2012
- 2012-05-21 US US13/476,851 patent/US8741945B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012515195A5 (https=) | ||
| US11691967B2 (en) | Antibiotics effective for gram-negative pathogens | |
| HU229935B1 (en) | Dual action antibiotics | |
| JP2010530881A5 (https=) | ||
| JP2006182786A5 (https=) | ||
| JP2011526283A5 (https=) | ||
| ES2520165T3 (es) | Derivados de desoxiactagardina | |
| JP2015505296A5 (https=) | ||
| JP2013511540A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2018515495A5 (https=) | ||
| JP2005523922A5 (https=) | ||
| JP2006143751A5 (https=) | ||
| JP2011509302A5 (https=) | ||
| JP2012506870A5 (https=) | ||
| JP2013542992A5 (https=) | ||
| JP2015521617A5 (https=) | ||
| US20240190872A1 (en) | Fabi inhibitors for gram-negative pathogens | |
| KR20110122139A (ko) | 액타가르딘 유도체 | |
| JP2023109937A (ja) | ３－置換１，２，４－オキサジアゾールの結晶形態 | |
| JP2011526286A5 (https=) | ||
| WO2011063764A1 (zh) | 阿齐沙坦有机胺盐及其制备方法和用途 | |
| EP4452967A2 (en) | Inhibitors of sars-cov-2 | |
| JP2014511897A5 (https=) | ||
| WO2020117755A1 (en) | Compositions and methods for treating biofilms |